Any side effects from taking omega-3 supplements are usually mild. They include an unpleasant taste in the mouth, bad breath, heartburn, nausea, stomach discomfort, diarrhea , headache, and smelly sweat. Omega-3 dietary supplements may interact with the medications you take.
Talk with your healthcare provider about possible interactions between omega-3 supplements and your medications. Foods contain vitamins, minerals, dietary fiber , and other components that benefit health.
In some cases, fortified foods and dietary supplements are useful when it is not possible to meet needs for one or more nutrients e. For more information about building a healthy dietary pattern, see the Dietary Guidelines for Americans and the U. This fact sheet by the Office of Dietary Supplements ODS provides information that should not take the place of medical advice.
We encourage you to talk to your healthcare providers doctor, registered dietitian, pharmacist, etc. Any mention in this publication of a specific product or service, or recommendation from an organization or professional society, does not represent an endorsement by ODS of that product, service, or expert advice.
Updated: August 4, History of changes to this fact sheet. Find ODS on:. Strengthening Knowledge and Understanding of Dietary Supplements. Health Information Health Information. Table of Contents What are omega-3 fatty acids and what do they do?
How much omega-3s do I need? What foods provide omega-3s? What kinds of omega-3 dietary supplements are available? Am I getting enough omega-3s? What happens if I don't get enough omega-3s? What are some effects of omega-3s on health? Can omega-3s be harmful? Do omega-3s interact with medications or other dietary supplements? Omega-3s and healthful eating Where can I find out more about omega-3s?
A meta-analysis of 13 observational 9 cross-sectional , 2 case-control , 1 nested case-control , and 1 prospective cohort ; 36, participants studies showed higher concentrations of omega-3 in blood and adipose tissue and higher level of omega-3 intake to be associated with a lower risk of metabolic syndrome No association was found between tissue omega-6 concentration or dietary omega-6 intake level and the risk of metabolic syndrome Alzheimer's disease is characterized by the formation of amyloid plaque in the brain and nerve cell degeneration.
Disease symptoms, including memory loss and confusion, worsen over time Observational studies: Several observational studies have examined dietary fish and PUFA consumption in relation to risks of cognitive decline, dementia , and Alzheimer's disease.
It was found that long-chain omega-3 PUFA supplementation did not increase plasma omega-3 concentrations to the same extent in E4 carriers than in non-carriers and that DHA metabolism differs in E4 carriers compared to non-carriers, with greater oxidation and lower plasma concentrations in E4 carriers However, neither APOE genotype nor polymorphisms in 11 other genes associated with Alzheimer's disease were found to modify the inverse relationship between fish intake and risk of cognitive decline in the pooled analysis of the five cohorts Results from two large cohort studies published after this dose-response meta-analysis showed blood DHA concentration to be positively associated with cognitive performance in adults , Randomized controlled trials: A systematic review identified three randomized controlled trials that examined the effect of omega-3 supplementation on the risk of cognitive decline in cognitively healthy older or elderly adults There was no evidence showing an effect of omega-3 on measures of cognitive functions in these clinical trials.
In a more recent systematic review that identified seven trials conducted in cognitively healthy participants, the authors reported positive effects of long-chain omega-3 supplementation on measures of cognitive outcomes in all studies but the second longest and the two largest trials Another seven trials examined the effect of long-chain omega-3 supplementation in individuals with mild cognitive impairment; all but three trials showed a significant benefit on measures of cognitive function or specific memory tasks Yet, two trials that found no improvement in cognitive performance included omega-3 supplements in both intervention and control arms , Overall, the data favor a role for diets rich in long-chain omega-3 fatty acids in slowing cognitive decline, but larger trials with longer intervention periods may be necessary to see a consistent beneficial effect of omega-3 supplementation in older individuals with normal or declining cognitive functions.
Several omega-3 fatty acid preparations have been approved by the US Food and Drug Administration for the treatment of hypertriglyceridemia Omega-3 supplementation also decreased inflammation as shown by a reduction in lipoprotein -associated phospholipase A2 and platelet activation as shown by a reduction in circulating concentrations of arachidonic acid , However, a residual elevation in triglycerides and triglyceride-rich lipoprotein cholesterol may remain in a substantial fraction of patients treated with statins.
The magnitude of these reductions in triglyceride and non-HDL-cholesterol concentrations was similar to what has been observed in other trials that examined the use of ethyl ester omega-3 supplements as add-ons to statin therapy , A study is underway to assess the benefit of combining omega-3 fatty acids and statins on the risk of major cardiovascular events over a three- to five-year period in patients with hypertriglyceridemia , Often associated with metabolic disorders, nonalcoholic fatty liver disease NAFLD is a condition characterized by an excessive lipid accumulation in the liver i.
Considering that C omega-3 PUFA can reduce fatty acid synthesis and inflammation , a possible therapeutic strategy would be to increase dietary intake of long-chain omega-3 PUFA. A meta-analysis of 18 randomized controlled trials in 1, participants with NAFLD found that omega-3 supplementation showed beneficial effects on liver fat, specific liver enzymatic activities, serum triglycerides , fasting glucose , and insulin resistance However, there was no evidence of an effect on total cholesterol , LDL -cholesterol, HDL -cholesterol, fasting insulin , blood pressure, BMI , and waist circumference Additional studies are needed to examine their efficacy in more severe cases of NASH.
A meta-analysis of 20 randomized controlled trials in 1, participants with rheumatoid arthritis assessed the efficacy of long-chain omega-3 PUFA supplementation on a series of clinical outcomes Omega-3 supplementation 0.
Blood concentrations of triglycerides 3 trials and pro-inflammatory leukotriene B4 5 trials were also decreased with supplemental omega-3 PUFA Another meta-analysis of 42 randomized controlled trials examined the effect of omega-3 supplementation mainly as fish oil on arthritic pain in patients diagnosed with different types of arthritis Daily administration of marine-derived EPA 0. The evidence of an effect of omega-3 supplements in patients with rheumatoid arthritis was deemed of moderate quality In a systematic review of 18 trials, including 1, subjects with rheumatoid arthritis, only 4 of 18 placebo-controlled trials showed a benefit of omega-3 PUFA supplementation 2.
Results of a few trials suggested that omega-3 PUFA could spare the need for anti-inflammatory medications in some patients yet failed to show superiority of PUFA in pain management , The limited body of evidence that suggests potential benefits of omega-3 supplementation in rheumatoid arthritis treatment needs strengthening with data from larger studies conducted for longer intervention periods , Crohn's disease: A systematic review evaluated the efficacy of omega-3 supplementation in patients with Crohn's disease , considering the evidence base from both short-term 9 to 24 weeks and long-term 1 year trials Among five trials that evaluated the efficacy of omega-3 supplementation on relapse rates, conflicting outcomes were reported.
Most trials were limited by small sample sizes and short duration — up to three years may be necessary to see an effect on relapse rates given the natural relapsing-remitting course of the disease.
The two largest and most recent trials EPIC-1 and EPIC-2 showed no significant effect of omega-3 supplementation on indicators of Crohn's disease remission compared to placebo Other systematic reviews of the literature reached similar conclusions Three short-term trials showed positive effects of omega-3 supplementation on plasma biochemical parameters e. In spite of its impact on biochemical changes in the short-term, however, the ability of omega-3 supplementation to maintain remission or effect clinically meaningful changes in Crohn's disease is not supported by the current evidence Ulcerative colitis: Seven randomized controlled trials of fish oil supplementation in patients with active ulcerative colitis reported significant improvement in at least one outcome measure, such as decreased corticosteroid use, improved disease activity scores, or improved histology scores In patients with inactive ulcerative colitis, omega-3 supplementation had no effect on relapse rates compared to placebo in four separate trials , While no serious side effects were reported in any trials of fish oil supplementation for the maintenance or remission of inflammatory bowel disease , diarrhea and upper gastrointestinal symptoms occurred more frequently with omega-3 treatment Inflammatory eicosanoids leukotrienes derived from arachidonic acid AA; n-6 are thought to play an important role in the pathology of asthma Because increasing omega-3 fatty acid intake has been found to decrease the formation of AA-derived leukotrienes, a number of clinical trials have examined the effects of long-chain omega-3 fatty acid supplementation on asthma.
Although there is some evidence that omega-3 fatty acid supplementation can decrease the production of inflammatory mediators in asthmatic patients , , evidence that omega-3 fatty acid supplementation decreases the clinical severity of asthma in controlled trials has been inconsistent Three systematic reviews of randomized controlled trials of long-chain omega-3 fatty acid supplementation in asthmatic adults and children found no consistent effects on clinical outcome measures, including pulmonary function tests, asthmatic symptoms, medication use, or bronchial hyperreactivity Immunoglobulin A IgA nephropathy is a kidney disorder that results from the deposition of IgA in the glomeruli of the kidneys.
Since glomerular IgA deposition results in increased production of inflammatory mediators, omega-3 fatty acid supplementation could potentially modulate the inflammatory response and preserve renal function. A meta-analysis assessed the efficacy of omega-3 fatty acid supplementation on adult IgA nephropathy Compared with control groups, omega-3 supplementation had no significant effect on urine protein excretion or glomerular filtration rate.
Only two trials measured changes in serum creatinine a marker of renal function and end-stage renal disease — omega-3 treatment had a beneficial effect on these two parameters in both trials.
No adverse events associated with omega-3 supplementation were reported in any of the trials. A more recent review of the literature identified six trials showing evidence of omega-3 supplementation slowing IgA nephropathy disease progression and three trials reporting no effect Additionally, preliminary data suggested that the potential synergistic actions of aspirin and long-chain omega-3 PUFAs might constitute a promising treatment option Autism spectrum disorders ASD refer to three neurodevelopmental disorders of variable severity, namely autism, Asperger syndrome, and pervasive development disorder.
ASD are characterized by abnormal information processing in the brain due to alterations in the way nerve cells and their synapses connect and organize. ASD are thought to have a strong genetic basis, yet environmental factors including diet may play an important role.
This is supported by observations of PUFA abnormalities in blood of children with ASD, when compared to their peers with no neurodevelopmental disorders A meta-analysis of case-control studies reported lower blood concentrations of DHA and EPA in children with ASD compared to typically developing children; yet, the ratio of total omega-6 to omega-3 fatty acids was similar between children with and without ASD symptoms A systematic review by the same authors identified six randomized controlled trials that examined the effect of primarily long-chain omega-3 PUFA on ASD symptoms Four trials used EPA 0.
A pooled analysis of four of these trials, including a total of participants, showed a small improvement in measures of social interaction and repetitive and restrictive interests and behaviors with long-chain PUFA supplementation for 6 to 16 weeks; however, there was no effect on measures of communication and ASD co-existing conditions, such as hyperactivity, irritability, sensory issues, and gastrointestinal symptoms Two additional systematic reviews and meta-analyses, also published in , identified the same set of trials.
One meta-analysis suggested a benefit of long-chain PUFA on measures of lethargy and stereotypy but found no overall clinical improvement compared to placebo The other meta-analysis suggested an improvement regarding lethargy yet a worsening of externalizing behavior and social skills in children supplemented with omega-3 PUFA The available evidence is based on few trials of small sample sizes and is thus too limited to draw firm conclusions regarding the potential benefit of long-chain PUFA supplementation in ASD management.
Data from ecologic studies across different countries suggested an inverse association between seafood consumption and national rates of major depression and bipolar disorder Several small studies have found omega-3 fatty acid concentrations to be lower in plasma and adipose tissue of individuals suffering from depression compared to controls. Although it is not known how omega-3 fatty acid intake affects the incidence of depression, modulation of neuronal signaling pathways and eicosanoid production have been proposed as possible mechanisms There may be some benefit of omega-3 PUFA supplementation on depressive disorders, but it is difficult to compare studies and draw conclusions due to great heterogeneity among the trials , Small sample sizes, lack of standardization of therapeutic doses, type of omega-3 PUFA administered, co-treatment with pharmacological agents, and diagnostic criteria vary among the trials.
A systematic review of all published randomized controlled trials investigated the effect of omega-3 PUFA supplementation on the prevention and treatment of several types of depression and other neuropsychiatric disorders With respect to major depression, most studies reported a positive effect of omega-3 supplements on depressive symptoms, though efficacy is still considered inconclusive given the great variability among trials.
A meta-analysis grouped trials by type of diagnosis of depression A positive effect of omega-3 supplementation was found in 11 trials in participants with a diagnosis of major depressive disorder according to the Diagnostic and Statistical Manual of Mental Disorders [DSM] criteria.
Omega-3 supplementation also appeared to be effective in the pooled analysis of eight trials in participants not formally diagnosed with major depressive disorder, i. There was no mood improvement with omega-3 supplements in generally healthy adults experiencing depressive symptoms, as suggested by the pooled analysis of six trials Finally, a Cochrane systematic review and meta-analysis of 20 randomized controlled trials reported a small benefit of omega-3 supplementation on depressive symptoms when compared to placebo , yet the evidence was deemed of very low quality and the positive effect was judged likely to be biased and not clinically significant Unipolar depression and bipolar disorder are considered distinct psychiatric conditions, although major depression occurs in both.
A meta-analysis of eight case-control studies that compared the PUFA composition of red blood cell membranes between patients with bipolar disorder and healthy subjects showed abnormally low red blood cell DHA concentrations with bipolar disorder As with major depression, reviews of trials indicated that omega-3 supplementation may have a positive effect as an adjunct to therapy in patients with bipolar disorder , Additionally, a randomized , placebo-controlled trial in participants with bipolar disorder reported a reduction in the severity of manic episodes with daily supplementation of 1, mg omega-3 PUFA for three months While there is some promising evidence for the use of omega-3 fatty acids for major depression and bipolar disorder, additional trials that account for dietary omega-3 intake, changes in red blood cell PUFA concentrations, the ratio of EPA:DHA provided, and co-treatment with medications are necessary.
A meta-analysis of 18 studies compared the PUFA composition of red blood cell membranes in patients with schizophrenia to individuals without the disorder Several mechanisms may account for PUFA abnormalities in schizophrenia, such as altered lipid metabolism , increased oxidative stress , or changes in diet consequent to disease-related behavior.
The use of long-chain omega-3 fatty acid supplements to alleviate symptoms of schizophrenia or to mitigate adverse effects of antipsychotic medications has been investigated in a number of clinical trials , In a recent randomized , placebo -controlled trial in 50 subjects with recent onset of schizophrenia who were medicated, daily supplementation with EPA mg and DHA mg reduced psychotic symptoms assessed with the Brief Psychiatric Rating Scale only in those who were not taking the anxiolytic , lorazepam Ativan Overall, however, there was no effect of long-chain PUFA supplements on schizophrenia symptoms.
Yet, given the high safety profile of fish oil supplements and some evidence of a positive effect of EPA supplementation in a subset of trials, some clinicians may consider EPA a useful adjunct to antipsychotic therapy in patients with schizophrenia. Several mechanisms suggest that omega-3 PUFA supplementation may improve the cognitive performance of individuals with Alzheimer's disease and other types of dementia.
In particular, the antioxidative and anti- inflammatory properties of these PUFA may help protect neurons , promote synaptic plasticity , and limit cellular death. The PUFA composition of the diet appears to influence blood cholesterol , which may play a role in the pathology of Alzheimer's disease. A Cochrane review identified three randomized , placebo -controlled trials in patients with Alzheimer's disease of mild-to-moderate severity These trials compared daily supplementation with DHA between mg and 1, mg and EPA between mg and mg to a placebo for 12 months , or 18 months Of note, the study by Quinn et al.
The pooled analysis of these trials showed no beneficial effect of omega-3 supplementation on measures of global and specific cognitive functions, measures of functional outcomes, and measures of dementia severity There was no difference between intervention and placebo arms regarding the occurrence of adverse effects Linoleic acid LA : Food sources of LA include vegetable oils, such as soybean, safflower, and corn oil; nuts ; seeds; and some vegetables.
Some foods that are rich in LA are listed in Table 2. Therefore, AA is absent in vegetable oils and fats and present in small amounts in meat, poultry, and eggs. Canola oil is also an excellent source of ALA. Some foods that are rich in ALA are listed in Table 3. Flaxseed oil also known as flax oil or linseed oil is available as an ALA supplement. A number of fish oils are marketed as omega-3 fatty acid supplements.
Cod liver oil is also a rich source of EPA and DHA, but some cod liver oil preparations may contain excessive amounts of preformed vitamin A retinol and vitamin D DHA supplements derived from algal and fungal sources are also available.
All omega-3 fatty acid supplements are absorbed more efficiently with meals. Dividing one's daily dose into two or three smaller doses throughout the day will decrease the risk of gastrointestinal side effects see Safety. Presently, manufacturers are not required to list the amounts of DHA and AA added to infant formula on the label. However, most infant formula manufacturers provide this information.
High doses of borage seed oil, evening primrose oil, or black currant seed oil may cause gastrointestinal upset, loose stools, or diarrhea Although flaxseed oil is generally well tolerated, high doses may cause loose stools or diarrhea Allergic and anaphylactic reactions have been reported with flaxseed and flaxseed oil ingestion Belching and heartburn have also been reported. Additionally, high doses may cause nausea and loose stools. Potential for excessive bleeding: The potential for high omega-3 fatty acid intakes, especially EPA and DHA, to prolong bleeding times has been well studied and may play a role in the cardioprotective effects of omega-3 fatty acids.
Although the US Institute of Medicine did not establish a tolerable upper intake level UL for omega-3 fatty acids, caution was advised with the use of supplemental EPA and DHA, especially in those who are at increased risk of excessive bleeding see Drug interactions and Nutrient interactions 1 , Potential for immune system suppression: Although the suppression of inflammatory responses resulting from increased omega-3 fatty acid intakes may benefit individuals with inflammatory or autoimmune diseases , anti-inflammatory doses of omega-3 fatty acids could decrease the potential of the immune system to destroy pathogens Studies comparing measures of immune cell function outside the body ex vivo at baseline and after supplementing people with omega-3 fatty acids, mainly EPA and DHA, have demonstrated immunosuppressive effects at doses as low as 0.
Although it is not clear if these findings translate to impaired immune responses in vivo , caution should be observed when considering omega-3 fatty acid supplementation in individuals with compromised immune systems. Potential other effects: Although fish oil supplements are unlikely to affect glucose homeostasis , people with diabetes mellitus who are considering fish oil supplements should inform their physician and be monitored if they choose to take them However, some preterm infants receiving fish oil-enriched formula had decreased plasma AA concentrations, which were associated with decreased weight but not length and head circumference , This effect was attributed to the potential for high concentrations of EPA to interfere with the synthesis of AA, which is essential for normal growth.
Randomized controlled trials have not found any adverse effects on growth in infants fed formulas enriched with AA and DHA for up to one year The safety of supplemental omega-3 and omega-6 fatty acids , including borage seed oil, evening primrose oil, black currant seed oil, and flaxseed oil, has not been established in pregnant or lactating breast-feeding women Some species of fish may contain significant levels of methylmercury, polychlorinated biphenyls PCBs , or other environmental contaminants In general, larger predatory fish, such as swordfish, tend to contain the highest levels of these contaminants.
Removing the skin, fat, and internal organs of the fish prior to cooking and allowing the fat to drain from the fish while it cooks will decrease exposure to a number of fat-soluble pollutants, such as PCBs However, methylmercury is found throughout the muscle of fish, so these cooking precautions will not reduce exposure to methylmercury.
Organic mercury compounds are toxic and excessive exposure can cause brain and kidney damage. The developing fetus, infants, and young children are especially vulnerable to the toxic effects of mercury on the brain. In order to limit their exposure to methylmercury, the US Food and Drug Administration FDA and Environmental Protection Agency have formulated joint recommendations for women who may become pregnant, pregnant women, breast-feeding women, and parents.
These recommendations are presented in Table 5. More information about mercury levels in commercial fish and shellfish is available from the FDA. Of note, the Dietary Guidelines for Americans recommend the consumption of salmon, anchovies, herring, shad, sardines, Pacific oysters, trout, and Atlantic and Pacific mackerel not king mackerel , which are higher in EPA and DHA and lower in methylmercury Although concerns have been raised regarding the potential for omega-3 fatty acid supplements derived from fish oil to contain methylmercury, PCBs, and dioxins, several independent laboratory analyses in the US have found commercially available omega-3 fatty acid supplements to be free of methylmercury, PCBs, and dioxins The absence of methylmercury in omega-3 fatty acid supplements can be explained by the fact that mercury accumulates in the muscle, rather than the fat of fish In general, fish body oils contain lower concentrations of PCBs and other fat-soluble contaminants than fish liver oils.
Additionally, fish oils that have been more highly refined and deodorized contain lower concentrations of PCBs Pyrrolizidine alkaloids, potentially hepatotoxic and carcinogenic compounds, are found in various parts of the borage plant. People who take borage oil supplements should use products that are certified free of unsaturated pyrrolizidine alkaloids High doses of black currant seed oil, borage seed oil, evening primrose oil, flaxseed oil, and fish oil may inhibit platelet aggregation; therefore, these supplements should be used with caution in people on anticoagulant medications In particular, people taking fish oil or long-chain omega-3 fatty acid EPA and DHA supplements in combination with anticoagulant drugs, including aspirin, clopidogrel Plavix , dalteparin Fragmin , dipyridamole Persantine , enoxaparin Lovenox , heparin, ticlopidine Ticlid , and warfarin Coumadin , should have their coagulation status monitored using a standardized prothrombin time assay international normalized ratio [INR].
Outside the body, PUFA become rancid oxidized more easily than saturated fatty acids. Inside the body, results of animal studies and limited data in humans suggest that the amount of vitamin E required to prevent lipid peroxidation increases with the amount of PUFA consumed One widely used recommendation for vitamin E intake is 0.
Although EPA and DHA are easily oxidized outside the body, it is presently unclear whether they are more susceptible to oxidative damage within the body High vitamin E intakes have not been found to decrease biomarkers of oxidative damage when EPA and DHA intakes are increased , , but some experts believe that an increase in PUFA intake, particularly omega-3 PUFA intake, should be accompanied by an increase in vitamin E intake 1.
The potential benefits associated with obtaining long-chain omega-3 fatty acids through moderate consumption of fish e. For information about contaminants in fish and guidelines for fish consumption by women of childbearing age, see Contaminants in fish. Seafood, nuts , seeds, and oils, which are all part of healthy dietary patterns, provide essential fatty acids.
The Dietary Guidelines provide dietary recommendations regarding the amounts of these foods for those who choose to follow a healthy US-style eating pattern, a healthy Mediterranean-style eating pattern, or a healthy vegetarian eating pattern Table 8. The American Heart Association recommends that people without documented coronary heart disease CHD eat a variety of fish preferably oily at least twice weekly Pregnant women and children should avoid fish that typically have higher levels of methylmercury see Contaminants in fish.
For adults, the World Health Organization recommends an acceptable macronutrient distribution range AMDR for omega-6 fatty acid intake of 2. The American Heart Association recommends that people without documented CHD eat a variety of fish preferably oily at least twice weekly The Linus Pauling Institute recommends that generally healthy adults increase their intake of long-chain omega-3 fatty acids by eating fish twice weekly and consuming foods rich in ALA, such as walnuts, flaxseeds, and flaxseed or canola oil.
If you don't regularly consume fish, consider taking a two-gram fish oil supplement several times a week. If you are prone to bleeding or take anticoagulant drugs, consult your physician.
Originally written in by: Jane Higdon, Ph. Updated in December by: Jane Higdon, Ph. Updated in April by: Victoria J. Drake, Ph. Updated in April by: Giana Angelo, Ph.
Updated in May by: Barbara Delage, Ph. Reviewed in June by: Donald B. Jump, Ph. Food and Nutrition Board, Institute of Medicine. Washington, D. The National Academies Press. Lichtenstein A, Jones PJ. Lipids: Absorption and Transport. Present Knowledge in Nutrition. Davidson MH. Omega-3 fatty acids: new insights into the pharmacology and biology of docosahexaenoic acid, docosapentaenoic acid, and eicosapentaenoic acid. Curr Opin Lipidol. Structure, function, and dietary regulation of delta6, delta5, and delta9 desaturases.
Annu Rev Nutr. Omega-3 fatty acid supplementation and cardiovascular disease. J Lipid Res. Br J Nutr. Burdge G. Docosahexaenoic acid concentrations are higher in women than in men because of estrogenic effects. Am J Clin Nutr. Delta-5 and delta-6 desaturases: crucial enzymes in polyunsaturated fatty acid-related pathways with pleiotropic influences in health and disease.
Adv Exp Med Biol. Genetic adaptation of fatty-acid metabolism: a human-specific haplotype increasing the biosynthesis of long-chain omega-3 and omega-6 fatty acids. Am J Hum Genet. Retroconversion and metabolism of [13C]n-3 in humans and rats after intake of a single dose of [13C]ntriacylglycerols. Dietary docosahexaenoic acid as a source of eicosapentaenoic acid in vegetarians and omnivores. Fatty acid-regulated transcription factors in the liver. Ann Rev Nutr. Stillwell W, Wassall SR.
Docosahexaenoic acid: membrane properties of a unique fatty acid. Chem Phys Lipids. Calder PC. Proc Nutr Soc. Polyunsaturated fatty acids and inflammatory processes: New twists in an old tale.
Omega-3 fatty acids in cardiac biopsies from heart transplantation patients: correlation with erythrocytes and response to supplementation. Jump DB. The biochemistry of n-3 polyunsaturated fatty acids. J Biol Chem. The role of docosahexaenoic acid in retinal function. The role of omega-3 long-chain polyunsaturated fatty acids in health and disease of the retina.
Prog Retin Eye Res. Innis SM. Dietary omega 3 fatty acids and the developing brain. Brain Res. Arachidonic acid stimulates glucose uptake in cerebral cortical astrocytes. Das UN, Fams. Long-chain polyunsaturated fatty acids in the growth and development of the brain and memory.
Das UN. Autism as a disorder of deficiency of brain-derived neurotrophic factor and altered metabolism of polyunsaturated fatty acids. American Oil Chemists' Society. August 15, Long-chain omega-3 fatty acids: time to establish a dietary reference intake. Nutr Rev. Serhan CN, Chiang N. Resolution phase lipid mediators of inflammation: agonists of resolution. Curr Opin Pharmacol. Bannenberg G, Serhan CN. Specialized pro-resolving lipid mediators in the inflammatory response: An update.
Biochim Biophys Acta. Front Immunol. Omega-3 polyunsaturated fatty acid regulation of gene expression. Dietary modification of inflammation with lipids. Sampath H, Ntambi JM. Polyunsaturated fatty acid regulation of gene expression. Shaikh SR. Biophysical and biochemical mechanisms by which dietary N-3 polyunsaturated fatty acids from fish oil disrupt membrane lipid rafts.
J Nutr Biochem. Essential fatty acid deficiency in patients receiving home parenteral nutrition. If you buy through links on this page, we may earn a small commission. Omega-3 fatty acids are a healthful and essential type of fat, and they offer many health benefits. Fatty fish is an excellent dietary source of omega People can also meet the recommended omega-3 intake by eating plant-based foods, including omegarich vegetables, nuts, and seeds.
Eating a variety of omega-3 sources is important. The following types of fish are some of the best sources of these fatty acids. For each fish below, the serving size is 3 ounces oz :. Along with omega-3s, mackerel is rich in selenium and vitamin B Salmon is one of the most popular and highly nutritious types of fish available.
There are several differences between wild and farmed salmon, including some variations in the omega-3 content. Salmon also contains high levels of protein, magnesium , potassium , selenium, and B vitamins. Learn more about the differences between wild and farmed salmon here. Oysters are a favorite shellfish that restaurants tend to serve as an appetizer or snack. Unlike many other seafood sources, oysters contain all three major classes of omega-3s.
In addition to omega-3s, trout is a good source of protein, potassium, and vitamin D. Seaweed, nori, spirulina, and chlorella are different forms of algae that many people eat for their health benefits. Seaweed and algae are important sources of omega-3 for people on a vegetarian or vegan diet, as they are one of the few plant groups that contain DHA and EPA. Seaweed is also rich in protein , and it may have antidiabetic, antioxidant, and antihypertensive properties.
People can find chlorella and spirulina in health-food stores or online. Shop here for chlorella and spirulina. Chia seeds are an excellent plant-based source of ALA omega-3 fatty acids. They are also high in fiber and protein. Chia seeds contain 5. People can use these seeds as an ingredient in granola, salads, or smoothies, or they can mix them with milk or yogurt to make chia pudding. Mixing chia seeds with water also creates an egg substitute that vegans can use. Many health-food stores now stock chia seeds, and it is also possible to buy them online.
Hemp seeds contain 2. Hemp seeds are slightly sweet and make an excellent addition to granola, oats, snack bars, salads, and smoothies.
0コメント